“Within our public sector programs, we continue to expect growth of over 900,000 Medicare Advantage members this year.”

In context

“eflects continued demand for our affordable solutions that give customers choice and simplify the pharmacy experience, such as biosimilar access and digital pharmacy tools. Part way into the ‘24 selling season, this momentum continues with strong client additions. OptumInsight revenues grew 42% to nearly $4.7 billion. The revenue backlog reached over $31 billion, an increase of $8 billion over last year, in part due to the addition of Change Healthcare. The integration and investment activities discussed on previous calls have gone well and are setting the stage for the next phase of growth for OptumInsight. Turning to UnitedHealthcare. Our commercial business added nearly 500,000 people in the first-half and continues its growth with the ‘24 selling season indications tracking favorably. Within our public sector programs, we continue to expect growth of over 900,000 Medicare Advantage members this year. And our Medicaid performance remains strong, as we continue to support states as they initiate redeterminations. Comprehensive outreach efforts to help individuals retain coverage are underway though it is still early as most states began this work only recently. Our capital capacities are strong. Adjusted cash flows from operations were at $10.4 billion or nearly 2 times net income in the second quarter and $15.6 billion or nearly 1.4 times net income in the first-half. In the first six 6 months of this year, we returned $8.3 billion to shareholders through dividends and share repurchases and in June, our Board of Directors increased the dividend by 14%. As Andrew mentioned, based upon our growth outlook and the trends discussed, today we were able to strengthen and narrow our full-year”